Sun Pharmaceutical Industries Limited Announced That One Of Its Wholly-Owned Subsidiaries Plans To Launch A First-In-Class Oral Drug, Bempedoic Acid, In India For Reducing Low-Density Lipoprotein (Ldl) Cholesterol. The Company Will Launch The Drug Under The Brand Name
